cagrisema vs semaglutide Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study Media Centre | EASD

This can lead to: Increased calorie burning Enhanced fat metabolism Reduced metabolic slowdown during weight loss This metabolic activity helps support continued progress rather than early plateaus

These medications mimic the action of the hormone GLP-1 (glucagon-like peptide-1), which helps manage blood sugar levels by stimulating insulin release, reducing glucagon secretion, and slowing gastric emptying

I notice my dark spots fading Appreciate the smooth process

It is crucial to note that the prescribing information for both drugs did not disclose any risks associated with similar gastrointestinal events or issue warnings regarding the potential development of gastroparesis